1991•PubMedRequires access

[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].

Maria Błasińska-Morawiec, Anna Pluzanska, Euzebiusz Krykowski, Tadeusz Robak, I Mrówka

Open publisher page 1 citations

Abstract

The results of the treatment with MOPP/COPP program for 114 patients with advanced Hodgkin's disease are presented. Complete remission has been achieved in 74 patients (65%). Thirty four of them (30%) are still remaining in first remission. The relapse of disease was observed in 37 patients, in 16 of them during first 24 months of follow-up. Three patients were lost of observation. The analysis of these unsatisfactory long-term results suggests that more effective management policies for patients with advanced Hodgkin's disease are needed.

About this research paper

What this paper is about

The results of the treatment with MOPP/COPP program for 114 patients with advanced Hodgkin's disease are presented. Complete remission has been achieved in 74 patients (65%). Thirty four of them (30%) are still remaining in first remission. The relapse of disease was observed in 37 patients, in 16 of them during first 24 months of follow-up. Three patients were lost of observation. The analysis of these unsatisfactory long-term results suggests that more effective management policies for patients with advanced Hodgkin's disease are needed.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The results of the treatment with MOPP/COPP program for 114 patients with advanced Hodgkin's disease are presented. Complete remission has been achieved in 74 patients (65%). Thirty four of them (30%) are still remaining in first remission. The relapse of disease was observed in 37 patients, in 16 of them during first 24 months of follow-up. Three patients were lost of observation. The analysis of these unsatisfactory long-term results suggests that more effective management policies for patients with advanced Hodgkin's disease are needed.

Key concepts: Procarbazine, COPP, Vincristine, Prednisone, Medicine, Cyclophosphamide, Disease, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)]. — Research Paper | ScholarLens